Mistras Group (MG) Q2 FY26 earnings call: guidance and Q&A

Confirming that the raised revenue guidance is driven by A&D and Infrastructure, with Oil & Gas expected to remain flat to down in the second half.

Management confirmed the assessment, stating that strength is seen in strategic growth markets (A&D, Infrastructure, Power), while Oil & Gas is expected to stabilize with flat to moderate growth in Q3 and Q4 after adjusting for exited programs and turnarounds.

“That's right, John. Yes, thanks for the question. It's indeed correct. We see strength in our strategic growth markets that we outlined there, Aerospace & Defense, Infrastructure, Power, and Oil & Gas is our core market. But there, what we see is more of a stabilization. Currently, we saw -- if we take out the turnaround and the exited programs, so we saw about 1% growth in Q2. So we anticipate sort of flat to moderate growth in Q2 and -- in Q3 and Q4. So that's how we look at it.”

asked by John Franzreb · answered by Natalia Shuman

Clarifying if the 'threefold' capacity expansion applies only to A&D projects or all lab-related work.

The threefold expansion is for in-lab work, which serves both Aerospace & Defense and Industrials markets. The company projects to triple its capacity by the end of 2027.

“Most is for in-lab work. So what we're doing is we're expanding our capacity in in-lab, and the markets that we serve in our laboratory operations is Aerospace & Defense and Industrials. So both markets will benefit from that expanded capacity. And we project, again, according to our strategic plan, our Vision2030, we project to triple our capacity by the end of '27.”

asked by John Franzreb · answered by Natalia Shuman

Inquiring if the 60% conversion of incremental revenue to operating income is sustainable.

The CFO confirmed that the 60% conversion rate (which was slightly higher for the full year) is sustainable, especially in the in-lab and data businesses due to their fixed cost elements, leading to attractive contribution margins as volume rises.

“Yes, that was for the second quarter. For the full year, it's actually slightly higher than that. And yes, there -- in the in-lab business, in the data business, there is a fixed cost element. So when volume rises, yes, there is a very attractive contribution margin drop down there. And you'll see that in many past quarters, when volume spikes up, you get a significant drop down there. So that's a good percentage to use in future periods. That's sustainable, absolutely.”

asked by John Franzreb · answered by Edward Prajzner

Seeking an explanation for the unusually high 'other revenue' number, which was double the prior quarter and higher than in previous years.

The CFO explained that 'other revenue' represents otherwise unclassified industries, comprising smaller call-out and project work that doesn't fit into predetermined end markets, highlighting the company's diversification. The CEO added cruise operators as an example.

“Sorry, that's the otherwise not classified industries. It's a lot of smaller call-out work. It's not fitting in the other predetermined end markets. But it's another example of our good diversification where we're picking up lots of work in different places beyond our core markets, but that's what that is a mix of industries and a lot of that's project work and call-out work in lots of different diverse places.”

asked by John Franzreb · answered by Edward Prajzner

Requesting discussion on backlog trends across segments.

Management clarified that visibility is not defined by a single backlog metric. For field services, it's recurring activity and long-standing contracts. For in-lab, it's reserved capacity and strategic agreements. Confirmed backlog exists for turnarounds and projects in Infrastructure and Power, but no single aggregate backlog figure is used.

“When we look at kind of backlog, we really not kind of define -- our visibility is not defined by like a single backlog metric. On the field side, our visibility is often better reflected by the recurring activity and long-standing kind of contracts and customer relationships and embedded integrated programs that we have.”

asked by Alex Riegel · answered by Natalia Shuman

Asking about the progress of building an M&A pipeline mentioned last quarter.

Management stated that the strategic plan doesn't rely on transformative M&A but they are opportunistically looking for opportunities to enhance capabilities and continue to build the pipeline, though nothing concrete can be shared at this time.

“So our strategic plan does not depend on any transformative M&A. So it's really -- it depends on executing on Vision2030 and strengthening our cash flow, reducing leverage. Having said that, we're obviously looking at opportunistic kind of opportunities where we can enhance our capabilities. So we continue to look and build the pipeline, but I cannot give you anything concrete at this time.”

asked by Alex Riegel · answered by Natalia Shuman

Inquiring about the sequential dip in in-lab revenue, the schedule for capacity milestones (3rd and 4th shares), and when these will impact revenue.

In-lab revenue largely depends on unlocking capacity, with a lead time of 9 to 12 months for investments to come online. Growth can vary quarter-on-quarter due to capacity constraints. The company is optimistic about this growth market due to customer demand and proactive capacity reservations, which will provide visibility into revenue growth as investments come online.

“Indeed, in-lab revenue is largely depends on the -- unlocking our capacity. So whenever we make an investment, there is a lead time until these investments will come online. So meaning that we can generate the revenue. Usually, the lead time is about 9 to 12 months. So as we continue to invest in the lab network, we would see that the growth could be slightly different quarter-on-quarter. So it cannot be exactly the same due to those -- some capacity constraints.”

asked by Gowshihan Sriharan · answered by Natalia Shuman